Literature DB >> 10400299

Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting.

M M Magalhães1, M E Pereira, C F Amaral, N A Rezende, D Campolina, F Bucaretchi, R T Gazzinelli, J R Cunha-Melo.   

Abstract

Seventeen patients stung by Tityus serrulatus scorpion were classified as mild (pain at the site of the sting, n = 6), moderate (local pain and one of the following manifestations: vomiting, psychomotor agitation, prostration, sweating, tachypnea, tachycardia and mild arterial hypertension, n = 10) and severe cases (equal moderate cases plus cardiac failure, pulmonary edema and shock, n = 1). Venous blood was sampled for biochemical and hematological analysis and for IL-1alpha, IL-6, IL-10, TNF-alpha, IFN-gamma and GM-CSF ELISAs at the time of hospital admission, 6 h (moderate and severe cases), and 12, 18, 36 and 72 h (severe case) later. Ten age-matched healthy volunteers were used as control. Increased serum levels of IL-1alpha was noticed in all patients, high levels of IL-6, IFN-gamma and GM-CSF were observed only in a patient with severe envenomation. Our data suggest that a systemic inflammatory response-like syndrome is triggered during severe envenomation caused by T. serrulatus sting and that release of cytokines may be involved in this response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400299     DOI: 10.1016/s0041-0101(98)00251-7

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  25 in total

1.  Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom.

Authors:  Wafa Medjadba; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Scorpion envenomation among children: clinical manifestations and outcome (analysis of 685 cases).

Authors:  Mabrouk Bahloul; Imen Chabchoub; Anis Chaari; Kamilia Chtara; Hatem Kallel; Hassen Dammak; Hichem Ksibi; Hedi Chelly; Noureddine Rekik; Chokri Ben Hamida; Mounir Bouaziz
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Macrophage activation, phagocytosis and intracellular calcium oscillations induced by scorpion toxins from Tityus serrulatus.

Authors:  V L Petricevich; E Reynaud; A H Cruz; L D Possani
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

4.  Clinical characteristics and outcome of children stung by scorpion.

Authors:  Ismail Lotfy Mohamad; Khalid I Elsayh; Hanaa A Mohammad; Khaled Saad; Asmaa M Zahran; Alameldin M Abdallah; M S K Tawfeek; Eman M Monazea
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

Review 5.  Immunological and toxinological responses to jellyfish stings.

Authors:  James Tibballs; Angel A Yanagihara; Helen C Turner; Ken Winkel
Journal:  Inflamm Allergy Drug Targets       Date:  2011-10

6.  Switch of Steady-State to an Accelerated Granulopoiesis in Response to Androctonus australis hector Venom.

Authors:  Asma Kaddache; Moustapha Hassan; Fatima Laraba-Djebari; Djelila Hammoudi-Triki
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

7.  Lung immunoreactivity and airway inflammation: their assessment after scorpion envenomation.

Authors:  Sonia Adi-Bessalem; Amina Mendil; Djelila Hammoudi-Triki; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 8.  Scorpion venom and the inflammatory response.

Authors:  Vera L Petricevich
Journal:  Mediators Inflamm       Date:  2010-03-14       Impact factor: 4.711

9.  Differential effect of Androctonus australis hector venom components on macrophage KV channels: electrophysiological characterization.

Authors:  Dalila Khemili; Carmen Valenzuela; Fatima Laraba-Djebari; Djelila Hammoudi-Triki
Journal:  Eur Biophys J       Date:  2018-07-13       Impact factor: 1.733

Review 10.  Emerging options for the management of scorpion stings.

Authors:  Jean-Philippe Chippaux
Journal:  Drug Des Devel Ther       Date:  2012-07-05       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.